Green Cross to develop cell-based pandemic vaccines
Published: 2010-04-09 06:57:00
Updated: 2010-04-09 06:57:00
Green Cross Corp., said on April 6 that it intends to enhance the nation’s preparedness for an influenza pandemic by improving on existing vaccine production techniques using egg-based vaccine, through the development of novel cell-based, pre-pandemic vaccines.
Pre-pandemic influenza vaccine i...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
